跳至主要内容
临床试验/EUCTR2011-005374-33-FI
EUCTR2011-005374-33-FI进行中(未招募)不适用

Safety and Immunogenicity of the Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Children Aged 3 to 8 Years

Sanofi Pasteur0 个研究点目标入组 1,225 人开始时间: 2013年4月25日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
1,225

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Children aged 3 to less than 9 years on the day of inclusion.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 1225
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Previous vaccination against influenza with the current seasonal vaccine formulation (as recommended by WHO), with either the trial vaccine or another vaccine.

研究者

相似试验

进行中(未招募)
不适用
Safety and Immunogenicity of a Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Adult and Elderly SubjectsProphylaxis of influenza in subjects from 18 years of ageMedDRA version: 14.0Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 10021881 - Infections and infestations
EUCTR2011-001976-21-DESanofi Pasteur1,568
进行中(未招募)
不适用
Safety and Immunogenicity of a Quadrivalent Influenza Vaccine inChild/Adolescent and Adult SubjectsProphylaxis of influenza in subjects from 9-17 years of age (and adults aged 18 to 60 years).MedDRA version: 14.1Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 10021881 - Infections and infestations
EUCTR2011-005101-79-Outside-EU/EEASanofi Pasteur2,083
进行中(未招募)
1 期
Immunogenicity and Safety of Quadrivalent Influenza Vaccine (VaxigripTetra™) inPregnant Wome
EUCTR2016-004763-40-FISanofi Pasteur729
已完成
3 期
Study of the Quadrivalent Influenza Vaccine in Participants 6 Months of Age and Older in India
CTRI/2021/11/037841Sanofi Healthcare India Private Limited SHIP400
进行中(未招募)
1 期
Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or Concomitantly with Two Other Vaccines in Healthy AdolescentsMeningococcal infectionMedDRA version: 20.0Level: PTClassification code 10027274Term: Meningococcal infectionSystem Organ Class: 10021881 - Infections and infestations
EUCTR2020-001665-37-ITSANOFI PASTEUR464